Science Wins Total Cancer - The World's First CDK4/6 Inhibitor Continues to Sound...

Every year on February 4th, World Cancer Day is established by the International Alliance against Cancer (UICC) and the World Health Organization (WHO) to promote cancer prevention and treatment worldwide, to raise the level of early diagnosis of cancer and reduce the incidence of cancer, and this year's theme is "Caring for Patients and Fighting Cancer Together "I am and I will".
years of joint efforts from all walks of life, we are pleased to see that the survival status of all types of cancer patients continue to improve, but at the same time, also need to pay attention to the incidence of various types of cancer is quietly changing.
The World Health Organization's International Agency for Research on Cancer (IARC) released the latest global cancer burden data for 2020, the world's new cancer cases in 2020 19.29 million cases, of which 2.26 million new cases of breast cancer, more than 2.2 million cases of lung cancer, breast cancer has replaced lung cancer as the world's largest cancer.
For Patients in China, breast cancer ranks first in the incidence of malignant tumors in women all year round, with about 304,000 cases per year, of which about 3% to 10% of women have distant metastasis at the time of diagnosis.
even in early stage patients, 30% to 40% develop advanced breast cancer.
the five-year survival rate of patients with advanced breast cancer in China is only 20%, and the overall medium survival time is 2 to 3 years, which is significantly lower than that of developed countries.
the same set of statistics from the IARC show that there will be 3 million cancer deaths and 120,000 breast cancer deaths in China by 2020.
In the past ten years, domestic clinical oncologists and related practitioners have been committed to improving the clinical treatment of breast cancer countermeasures, from surgical treatment, chemotherapy, endocrine therapy to today's targeted treatment, advanced breast cancer treatment methods continue to emerge and change, so that the survival of patients can be greatly extended, but also obtained a "dignity of survival."
breast cancer has become a "preventable and treatable" chronic disease, which is a stage victory for cancer prevention and treatment in China.
, longer disease management times also bring more clinical challenges.
health China Action - Cancer Prevention and Control Implementation Program (2019-2022) jointly issued by various ministries in 2019, the goal of early diagnosis and treatment of breast cancer, standardized diagnosis and treatment, and improving the overall survival rate is emphasized.
patient-centered, "all-round, full-cycle" "two-full" disease management concept, has become the next stage of breast cancer treatment in China an important point.
Professor Xu Binghe, director of the National Center for New Drugs (Anti-Tumor) Clinical Research (GCP) of the National Cancer Center/Chinese Academy of Medical Sciences Cancer Hospital and chairman of the National Cancer Expert Committee of the National Cancer Quality Control Center, said: "The overall level of breast cancer treatment in China has made remarkable progress in recent years, with the five-year survival rate of patients exceeding 83%, but there is still a gap between the United States and the United States, which is as high as 90 percent."
First of all, because breast cancer screening and early diagnosis is not as good as in Western countries, developed countries in the phase I detection rate of more than 40%, and China's phase I detection rate of about 20% to 25%;
in order to regulate breast cancer screening, treatment and follow-up, domestic associations and institutions have also developed a number of guidelines and norms, hope that the future clinical treatment of breast cancer will be more and more standardized.
" In the scientific power to overcome diseases at the same time, medical institutions, medical experts, pharmaceutical companies, insurance companies and third-party institutions are working closely together to create a full range of medical health ecosystem, with science and technology to enhance the humane care of cancer patients and innovative treatment access.
Innovative "Hui Chang Care" online patient integrated service platform, so that patients can get the authority of professional patient education live, convenient and fast online drug purchase map, easy to find drugs (cloud pharmacy) and other convenient multi-dimensional patient services.
on this basis, all walks of life are still vigorously promoting China's diagnosis and treatment technology, the concept of continuous progress, to maximize the satisfaction of China's advanced breast cancer patients unsophatic medical needs, to help patients with scientific anti-cancer, with the power of love to break through the impossible life!